FDA
Entity.
- Evidence
- 2,735 documents · 241 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 Apr 2026, last seen 27 Oct 2026
- Measured
- 35% of mentions say something specific about it; the rest only name it
- As of
- 29 Oct 2026
Where this comes from
- PR Newswire · 2026-10-27 · FDA Selects Patient-Led Nonprofit to Develop Pancreatitis Flare Endpoint for Clinical Trials (opens the source in a new tab)
- Medical Daily · 2026-10-27 · FDA Launches New Neuroscience Program to Improve Alzheimer's Prevention Trials and Support Future Treatments for Brain Disorders (opens the source in a new tab)
- FDA Drug News · 2026-10-27 · FDA Drug Topics Webinars (opens the source in a new tab)
- J Gastrointest Cancer · 2026-10-26 · Signal Mining of Adverse Events of Antiangiogenic Drugs in Colorectal Cancer Based on the FDA Adverse Event Reporting System (FAERS) Database. (opens the source in a new tab)
- Intelligent Living · 2026-10-26 · Over 1,000 FDA-Cleared AI Devices: Where They Actually Work in Hospitals (opens the source in a new tab)
- Psychedelic Alpha · 2026-10-26 · Mostly Supportive, Somewhat Divided: Stakeholders Respond to FDA’s Psychedelics Docket (opens the source in a new tab)
- Tech Times · 2026-10-26 · Israel Opens First National MDMA-Psilocybin PTSD Trial After FDA Rejection (opens the source in a new tab)
What is claimed about it
- Corroborated: Reported by three or more sources that did not copy each other.
- Reported by two: Reported by two sources that did not copy each other.
- Single source: Reported by one source so far.
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies Single source · first reported 27 Oct 2026
- FDA approves talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer with HRR gene mutations Corroborated · first reported 26 Oct 2026
- fda approved over-the-counter weight loss drugs 2026 Could not check · first reported 25 Oct 2026
- FDA Launches New Accelerator for Alzheimer’s Disease Prevention Reported by two · first reported 23 Oct 2026
- Lord's Mark Industries Secures US FDA Registration For 200 Products For December US Exports Could not check · first reported 23 Oct 2026
- Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S. Single source · first reported 23 Oct 2026